Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MAYNE PHARMA GROUP LIMITED Capital/Financing Update 2016

Jul 5, 2016

65396_rns_2016-07-05_45c0d2fb-c848-4ca6-a74c-ecd3010432ad.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Notice

Notice reference number: 0792.16.07

Notice date: 06/07/2016

What’s this about?

Effective date: 06/07/2016

==> picture [505 x 89] intentionally omitted <==

----- Start of picture text -----

 ASX Trade ASX 24 ASX TECH
 Trading Clearing Settlement ALC ASX NET
Operations Technology Market Data Rules  Compliance Risk  Other
----- End of picture text -----

Title

Mayne Pharma Group Limited – Accelerated Non Renounceable Entitlement Offer

1Description

On 28 June 2016, Mayne Pharma Group Limited (ASX Code: MYX) (Company) announced a fully underwritten 1 for 1.725 accelerated non-renounceable pro-rata entitlement offer of new ordinary shares in the Company at an issue price of $1.28 per new share to raise approximately $601 million (Entitlement Offer).

The Entitlement Offer has the following two components.

  • An institutional entitlement offer, where offers have been made to eligible institutional shareholders for them to apply for their pro-rata entitlement (Institutional Entitlement Offer).

  • A retail entitlement offer, where offers will be made to eligible retail shareholders for them to apply for their pro-rata entitlement (Retail Entitlement Offer).

New ordinary shares issued under the Entitlement Offer will rank equally in all respects with existing ordinary shares.

The anticipated timetable in relation to the Entitlement Offer is set out below.

Date Event
Tuesday, 28 June 2016 Trading Halt commences
Announcement of Entitlement Offer
Thursday, 30 June 2016 Announce results of Institutional Entitlement Offer
Trading halt lifted
Trading in ordinary shares resumes on an ex-entitlement basis (ASX Code: MYX)
Thursday, 30 June 2016 Record Date for Entitlement Offer
Monday, 4 July 2016 Retail Entitlement Offer opens
Wednesday, 6 July 2016 Settlement of Institutional Entitlement Offer
Thursday, 7 July 2016 Quotation of new shares issued under the Institutional Entitlement Offer (ASX Code:
MYX)
Friday, 15 July 2016 Retail Entitlement Offer closes

1/2

ASX Notice

(continued)

Thursday, 21 July 2016 Settlement of Retail Entitlement Offer
Monday, 25 July 2016 Quotation of new shares issued under Retail Entitlement Offer (ASX Code: MYX)

Settlement issues

Despite the fact that securities are trading ‘ex entitlement’ on ASX Trade, CHESS will not recognise for settlement purposes the ‘ex entitlement’ or the ‘cum entitlement’ tag on CHESS messages and CHESS will not maintain cum balances during the deemed ‘CHESS ex-period’, i.e. the period commencing on the deemed CHESS ex-date up to and including the record date. However, a record date cum balance will be available the business day following the record date, which will be equal to the registered holding balance at CHESS end of day on the record date. As a result any transfer that occurs prior to record date will be effectively transferred on a ‘cum entitlement’ basis.

Therefore, Participants must ensure that any transfer, including the priming of Broker Entrepot Accounts, is conducted in accordance with the basis of quote. For example, a transfer in relation to a transaction conducted on an ‘ex entitlement’ basis should ordinarily only occur post record date.

CHESS will perform automatic diary adjustments to ‘cum entitlement’ settlement obligations outstanding as at the record date.

Trading issues

ASX will not price a ‘cum entitlement’ market with respect to trading in the Company’s securities. Persons who acquire the Company’s securities after the commencement of the trading halt on Tuesday, 28 June 2016 are not entitled to participate in the Entitlement Offer.

What do I need to do and by when?

For further details, please refer to the Company’s announcements.

Need more information?

For further information, please contact the Company’s Entitlement Offer Information Line on 1300 850 505 within Australia or +61 3 9415 4000 outside Australia from 8.30am to 5:00 pm (Melbourne time) Monday to Friday.

Issued by Cheng Tang

4

Contact Details

(03) 9617 8706

Disclaimer

2/2